Patents by Inventor Nathalie Louise Mathy

Nathalie Louise Mathy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE
    Publication number: 20100184836
    Abstract: This invention relates to novel HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef which are useful in immunogenic compositions and vaccines. The invention relates in particular to a polypeptide which comprises Nef or an immunogenic fragment thereof, and p17 Gag and/or p24 Gag or immunogenic fragments thereof, wherein when both p17 and p24 Gag are present there is at least one HIV antigen or immunogenic fragment between them. The polypeptide may also comprise Pol or RT or an immunogenic fragment thereof.
    Type: Application
    Filed: October 14, 2009
    Publication date: July 22, 2010
    Inventors: Helge ABRECHT, Martine Delchambre, Martine Marchand, Nathalie Louise Mathy, Philippe Jean Gervais Ghislain Permanne, Gerald Hermann Voss
  • Vaccine for prevention and treatment of HIV-infection
    Patent number: 7612173
    Abstract: This invention relates to novel HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef which are useful in immunogenic compositions and vaccines. The invention relates in particular to a polypeptide which comprises Nef or an immunogenic fragment thereof, and p17 Gag and/or p24 Gag or immunogenic fragments thereof, wherein when both p17 and p24 Gag are present there is at least one HIV antigen or immunogenic fragment between them. The polypeptide may also comprise Pol or RT or an immunogenic fragment thereof.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: November 3, 2009
    Assignee: GlaxoSmithKline Biologicals, s.a.
    Inventors: Helge Abrecht, Martine Delchambre, Martine Marchand, Nathalie Louise Mathy, Philippe Jean Gervais Ghislain Permanne, Gerald Hermann Voss
  • Novel composition
    Publication number: 20040131638
    Abstract: The present invention relates to a vaccine composition comprising at least one human immunodeficiency virus (HIV) antigen and either one or both of: i) at least one herpes simplex virus (HSV) antigen and ii) at least one human papillomavirus (HPV) antigen.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 8, 2004
    Inventors: Serge Debrus, Nathalie Louise Mathy, Gerald Voss